Evolent Health (EVH)
(Delayed Data from NYSE)
$9.98 USD
-0.07 (-0.70%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $9.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
EVH 9.98 -0.07(-0.70%)
Will EVH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EVH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EVH
iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline
EVH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Evolent Health (EVH) Stock Jumps 6.9%: Will It Continue to Soar?
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
Evolent Health (EVH) Q1 Earnings Lag Estimates
Other News for EVH
Truist Securities Raises Price Target for Evolent Health (EVH) | EVH Stock News
Evolent Health (EVH) Target Price Increased as Analyst Remains Positive | EVH Stock News
Evolent Health price target raised by $2 at Truist, here's why
The Analyst Verdict: Evolent Health In The Eyes Of 5 Experts
Evolent Health Inc (EVH) Announces Upcoming Financial Results Release and Conference ...